Yiling got an approval letter for Acyclovir Tablets USP 400mg and 800mg on March 8 from FDA in only 10 months after the submission of the ANDA dossier. Acyclovir Tablet is Yiling’s first ANDA approved by FDA, marking the beginning of Yiling’s entrance into US market.

Business Scope

Own Drugs Development, Registration and Marketing

In/Out Licensing

■ Contract Manufacture:Commercial product 

■ Contract Manufacture: Small batches for clinical trial